From 2b53cccfb4be093a2d31452c56b77aaf04e10056 Mon Sep 17 00:00:00 2001 From: Borja Robert Date: Tue, 20 Feb 2024 12:33:07 +0100 Subject: [PATCH] Auto saved by Logseq --- pages/STOP2030___Web___Update 2024___02.md | 3 +++ 1 file changed, 3 insertions(+) diff --git a/pages/STOP2030___Web___Update 2024___02.md b/pages/STOP2030___Web___Update 2024___02.md index c6e4983d..9663c600 100644 --- a/pages/STOP2030___Web___Update 2024___02.md +++ b/pages/STOP2030___Web___Update 2024___02.md @@ -87,4 +87,7 @@ - Especificar que la novel formulation es una fixed-dose coformulation de [[Ivermectina]] y [[Albendazol]]. - Especificar que esta fixed-dose coformulation de ivm/alb has the lowest [[level]] of investment risk of all candidates for Combinations for [[STH]] treatment (fuente: Soil Transmitted Helminths Drug Combinations Expert Meeting, 2016, Gates Foundation) - Una referencia explícita al Estudio ALIVE: https://gatesopenresearch.org/articles/6-62/v1 + - Los achievements de los STOP previos + - Qualification at EMA for [[article]] 58 (ahora se llama Meds4All, creo) + - Proved safety - \ No newline at end of file